Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Imaging companies join forces to deliver AI-guided echocardiography exams

The collaboration, announced at ASE 2023, was launched in the name of patient access. 

Shopping Cart ECG electrocardiogram AFib atrial fibrillation

Cardiology at the supermarket: Shopping carts upgraded to detect signs of AFib

Attaching ECG sensors to the handles of shopping carts could help identify signs of atrial fibrillation in patients who don't even realize they have it. 

The ReCor (left) and Medtronic Symplicity Spyral renal denervation systems.

FDA panel to review renal denervation system PMA submissions

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

artificial intelligence robot evaluates healthcare data

FDA grants breakthrough designation for new AI model to detect cardiac amyloidosis in ECG results

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

Artificial intelligence automated measurements on an echocardiogram on the Siemens SyngoDynamics cardiovascular imaging and information solution. AI is helping speed workflows and complete tedious tasks faster and more accurately that humans, allowing sonographers and cardiologists to be more efficient. Photo by Dave Fornell

AI technologies to be featured heavily at ASE 2023

Artificial intelligence will be one of the hottest topics at the upcoming American Society of Echocardiography meeting in National Harbor, Maryland. 

Thumbnail

Photon-counting technology offers new opportunities in imaging high-risk CAD patients

Coronary CT angiography is commonly used to assess patients at low or intermediate risk of CAD but is less effective in high-risk patients with an increased presence of coronary calcifications and stents due to the “blooming” effect they have on imaging.

The Surdonics SurVeil drug-coated balloon to treat peripheral artery disease.

FDA approves next-gen DCB, earning the manufacturer a $27M payment from Abbott

The new-look DCB was designed to provide care with a significantly lower drug load than similar devices. 

A TAVR procedure being performed at Northwestern Medicine in Chicago. These structural heart procedures require a team approach.

Heart damage after TAVR: Follow-up imaging helps cardiologists anticipate problems

While cardiac damage reverses in many patients following treatment, it can actually continue to get worse in others. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.